NASDAQ · Drug Manufacturers - Specialty & Generic

PRFX (PRFX) Stock

$1.09 -3.96% NASDAQ: PRFX Healthcare

Valuation

MetricValue
Price$1.09
Market Cap$87780
P/E Ratio-0.26
P/B Ratio0.19
P/S Ratio90.92
EPS (TTM)$-7.47
52-Week High$17.95
52-Week Low$1.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-90.37%
ROA-38.75%
ROCE-55.56%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio2.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-7.0M$-9.0M$-10.0M$-15.0M$-5.0M
Net Profit$-7.0M$-9.0M$-9.0M$-15.0M$-5.0M
EPS$-4430.82$-4948.02$-4283.23$-804.00$-7.47
Op Margin—-10312.8%——-29335.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$19.0M$12.0M$10.0M$5.0M$12.0M
Total Liabilities$1.0M$1.0M$3.0M$3.0M$3.0M
Cash$17.0M$4.0M$8.0M$4.0M$4.0M
Borrowings$0$0$0$0$0

Latest News

PRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026 GlobeNewswire · Jul 21, 2026 PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets GlobeNewswire · Jul 15, 2026 PRF Technologies’ DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market Data GlobeNewswire · Jul 8, 2026 Sector Update: Healthcare Stocks Gain Late Afternoon MT Newswires · Jun 25, 2026 Sector Update: Healthcare Stocks Advance in Afternoon Trading MT Newswires · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-6.0M$-7.0M$-13.0M$-4.0M
Investing Cash Flow$0$-6.0M$6.0M$0$-1.0M
Financing Cash Flow$1.0M$0$3.0M$4.0M$0
Net Cash Flow$1.0M$-12.0M$4.0M$-4.0M$0
Free Cash Flow$-7.0M$-6.0M$-7.0M$-13.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.40
FCF Yield-2541.73%
Quick Ratio1.78
Interest Coverage—
Return 1Y-82.95%
Return 3Y-99.48%
Return 5Y-99.85%

Ownership

Insiders Held0.00%
Institutions Held0.52%
Institutions Float Held0.52%
Institutional HolderSharesReport Date
Citadel Advisors Llc13,2202026-03-31
Morgan Stanley1,6112026-03-31
UBS Group AG8692026-03-31
Osaic Holdings Inc.402026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATXIAvenue Therapeutics, Inc. $0.26 -32.94% -0.49 $856691 0.00%
DRMA $1.10 -0.90% -0.15 $749713 0.00%
ELAB $0.92 +2.21% 0.00 $1.78M 0.00%
NCEL $3.60 -4.13% -0.13 $1.62M 0.00%
NKGNNKGen Biotech, Inc. $0.06 +0.00% -0.04 $7.84M 0.00%

About PRFX

PRFX is led by CEO Efraim Cohen-Arazi, publicly traded since 2020.

PRFX stock trades at $1.09 with a market capitalization of $87780. The stock is valued at a price-to-earnings (P/E) ratio of -0.26, price-to-book of 0.19, price-to-sales of 90.92. Over the past 52 weeks the stock has ranged between $1.09 and $17.95, and currently trades 93.9% below its 52-week high.

On profitability, PRFX generates a return on equity (ROE) of -90.37%, return on capital employed of -55.56%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides